MARKET

ATRC

ATRC

Atricure
NASDAQ
22.61
-0.44
-1.91%
After Hours: 22.65 +0.04 +0.18% 16:35 04/25 EDT
OPEN
22.62
PREV CLOSE
23.05
HIGH
22.88
LOW
22.07
VOLUME
326.85K
TURNOVER
0
52 WEEK HIGH
59.61
52 WEEK LOW
22.07
MARKET CAP
1.09B
P/E (TTM)
-34.3983
1D
5D
1M
3M
1Y
5Y
AtriCure upgraded at Oppenheimer on valuation
Oppenheimer upgraded AtriCure to Outperform from Perform. The cardiac device maker's shares traded higher premarket Tuesday. Oppenheimer says the company's valuation is attractive compared to its small-cap MedTech peers. The firm issued a $32 per share target on the stock.
Seeking Alpha · 2d ago
ATRICURE <ATRC.O>: OPPENHEIMER RAISES TO OUTPERFORM FROM PERFORM
Reuters · 2d ago
AtriCure Price Target Announced at $32.00/Share by Oppenheimer
Dow Jones · 3d ago
AtriCure Raised to Outperform From Perform by Oppenheimer
Dow Jones · 3d ago
Oppenheimer Upgrades AtriCure to Outperform, Announces $32 Price Target
Benzinga · 3d ago
Weekly Report: what happened at ATRC last week (0415-0419)?
Weekly Report · 4d ago
Weekly Report: what happened at ATRC last week (0408-0412)?
Weekly Report · 04/15 11:32
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
Needham sees BSX, CNMD, RMD and Surmodics beating Street, despite medtech slow down. Needham estimates medtech sales grew less than expected in Q1, but that Boston Scientific, CONMED and ResMed should still beat the Street. The investment firm says medtech market only grew by 5.3% in the first quarter of 2024.
Seeking Alpha · 04/14 21:56
More
About ATRC
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.

Webull offers AtriCure Inc stock information, including NASDAQ: ATRC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATRC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ATRC stock methods without spending real money on the virtual paper trading platform.